Li-Sheng Lu
10Patents
5h-index
21Co-inventors
62Inventor score
Filing activity: Sep 26, 2006 → Apr 3, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8124738B2 | Human monoclonal antibodies to CD70 | Emerging Cross-Sectional Technologies | 51 | Active |
| US9102738B2 | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) | Chemistry; Metallurgy | 12 | Active |
| US8680247B2 | Monoclonal antibodies against glypican-3 | Chemistry; Metallurgy | 9 | Active |
| US8609816B2 | Human monoclonal antibodies to O8E | Chemistry; Metallurgy | 8 | Active |
| US8222375B2 | Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies | Chemistry; Metallurgy | 6 | Active |
| US9296822B2 | Human monoclonal antibodies to O8E | Chemistry; Metallurgy | 5 | Active |
| US9988453B2 | Human monoclonal antibodies to O8E | Chemistry; Metallurgy | 1 | Active |
| US9217033B2 | Monoclonal antibodies against Glypican-3 | Chemistry; Metallurgy | 0 | Active |
| US12110337B2 | Anti-CD27 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US9505845B2 | Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.